Cencora, Inc. (COR) Stock
COR Key Statistics
About Cencora, Inc.
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
CEO: Robert Mauch. Company website
COR — Frequently Asked Questions
What is the COR stock price today?
Cencora, Inc. (COR) trades at $308.78, down 0.20% on the day, as of Sep 20, 2026 12:32 UTC.
What is Cencora, Inc.'s market cap?
Cencora, Inc. has a market capitalisation of $60.08B, calculated from the live COR share price and shares outstanding.
What is the P/E ratio of COR?
COR trades at a trailing P/E of 22.94, from earnings per share of $13.46 over the last twelve months.
How much revenue does Cencora, Inc. make?
Cencora, Inc. generated revenue of $332.77B over the trailing twelve months, which puts the stock at 0.18 times sales.
Does COR pay a dividend?
Yes. Cencora, Inc. pays a dividend yielding 0.64% on the current share price.
What is the 52-week range for COR?
COR has traded between $244.82 and $377.54 over the past 52 weeks, and the last price is 18.2% below that high.
Is Cencora, Inc. profitable?
Yes. Cencora, Inc. keeps 0.79% of revenue as net income over the trailing twelve months.
What is the analyst price target for COR?
Wall Street analysts rate COR Buy, with an average price target of $358.14, 16.0% above the current price.
What sector is Cencora, Inc. in?
Cencora, Inc. is classified under the Healthcare sector and the Medical - Distribution industry, and is domiciled in US.
Who is the CEO of Cencora, Inc.?
Robert Mauch is the chief executive of Cencora, Inc., which employs 49,000 people.
Where can I track COR in real time?
QFI Terminal shows COR with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See COR live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open COR in Terminal See plans